20E
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 20E, covering 2026-02-13 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. [Phase 2]